Hub City Orthodontics, P.a. Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 1118 Klick Way, Hagerstown, MD 21742 Phone: 301-733-5230 Fax: 301-733-5367 |
Dentistry At Hagerstown Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1329 Pennsylvania Ave Ste 201, Hagerstown, MD 21742 Phone: 301-791-0333 |
Jeffrey Pearlman D.d.s., P.a. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 18638 Crestwood Dr, Hagerstown, MD 21742 Phone: 301-797-6950 Fax: 301-797-4484 |
Antietam Periodontics Pa Drs. Fred & Rebecca Bye Dentist - Periodontics Medicare: Not Enrolled in Medicare Practice Location: 13424 Pennsylvania Ave Ste 201, Hagerstown, MD 21742 Phone: 301-739-6868 Fax: 301-790-4990 |
Walnut Street Community Health Center / Dental Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 201 S Cleveland Ave, Hagerstown, MD 21740 Phone: 301-745-3777 Fax: 301-393-3463 |
News Archive
Genomic sequencing experts at Johns Hopkins partnered with pharmacologists at Stony Brook University to reveal a striking mutational signature of upper urinary tract cancers caused by aristolochic acid, a plant compound contained in herbal remedies used for thousands of years to treat a variety of ailments such as arthritis, gout and inflammation.
Some women in African nations are "dangerously confused about the best nutritional path to protect their children from contracting [HIV]," a new report, based on research by community health workers from Cameroon, Cote d'Ivoire, Ethiopia, and Nigeria, shows, PlusNews reports.
RadNet, Inc., a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 191 fully owned and operated outpatient imaging centers, today reported it has executed a definitive agreement to acquire Image Medical Corporation, the parent of eRAD, Inc., for $10.75 million in a combination of cash and promissory notes.
Identifying the molecular profile of a tumour where the primary site is unknown is crucial to the choice of treatment, the 2013 European Cancer Congress, will hear on Monday.
› Verified 2 days ago